Home / Medicine / Mobic

Mobic

Mobic contains meloxicam, a nonsteroidal anti-inflammatory drug, and is registered in 26 countries across Europe, Asia-Pacific, and the Americas. It is one of the more recognisable meloxicam brands on the international market, although it sits alongside a range of generic meloxicam products in many of the same jurisdictions.

Meloxicam is used in the management of inflammatory and degenerative joint conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, spondyloarthritis, and juvenile rheumatoid arthritis. Within the broader nonsteroidal anti-inflammatory category it is described as having analgesic, anti-inflammatory, antipyretic, and cyclo-oxygenase-inhibitory properties. The structured indication block further down this page lists the registered uses recognised by national regulators in each market where Mobic is sold.

Mobic's footprint spans markets as varied as Japan, France, Australia, Argentina, and Malaysia, which means a traveller or expatriate moving between these regions has a reasonable chance of finding the same brand under the same name. Where Mobic itself is not on the shelf, meloxicam as an active ingredient is generally available under other brand names, and the broader nonsteroidal anti-inflammatory class is represented in essentially every regulated pharmacy market in the world. A local pharmacist is usually the right first point of contact for confirming what is registered nationally.

Decisions about long-term anti-inflammatory therapy for chronic joint conditions are individual and depend on the patient's overall clinical picture. Anyone using Mobic, considering it, or trying to identify a regional equivalent should treat the conversation as a clinical one with their own healthcare provider rather than a matter of brand recognition.

Countries
Argentina Australia Belgium China Colombia Ecuador Finland France Hong Kong Ireland Italy Japan Lebanon Malaysia Malta New Zealand Oman Peru Philippines South Africa South Korea Taiwan Thailand Tunisia USA Vietnam
Diseases
Arthritis,Osteoarthritis Rheumatoid Arthritis Ankylosing Spondylitis Osteoarthritis Spondyloarthritis Juvenile Rheumatoid Arthritis
Ingredients
Meloxicam
Drug Actions
Analgesic Pain reliever Anti-inflammatory Antipyretic Cox inhibitory Nonsteroidal anti-inflammatory
How does this drug class actually work?
Read the plain-language explainer in Pharmacology Academy (Non-steroidal anti-inflammatory drugs) →

Drugs with the same active ingredients

Aldoron Aldoron flex Acticam Bronax Bronax flex Dolo adaxil Dolo asotrex Dolo baliartrin Dolo findol Dolo glucoarrumalon Dolo glucotrin Dolo mecanyl Dolo mecanyl (nsaid) Dominadol Flexidol Flexidol (nsaid) Flexidol relax Flexidol relax (meloxicam,pridinol) Flexium Loxitenk

Frequently asked questions

What conditions does Mobic treat?

Mobic is prescribed in the management of inflammatory and degenerative joint conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, spondyloarthritis, and juvenile rheumatoid arthritis. As a nonsteroidal anti-inflammatory, it is described in the categories of analgesic, anti-inflammatory, and antipyretic action. The full registered indication list for the markets where Mobic is sold appears in the structured section below this introduction.

Which active substance is in Mobic?

Mobic contains meloxicam, a nonsteroidal anti-inflammatory drug with cyclo-oxygenase-inhibitory activity. Meloxicam circulates internationally under the Mobic brand and under a number of generic and alternative brand names, particularly in markets where the original patent has expired. The molecule itself is the same regardless of the commercial label under which it is dispensed.

In how many countries is Mobic available?

Mobic is registered in 26 countries spanning multiple regions. Examples include Japan, France, Argentina, Australia, China, Belgium, and Malaysia. The list reflects a broad rather than universal footprint, so if your country is not represented a local pharmacist can usually confirm whether meloxicam is available under another brand name or as a generic product in that market.

Are there other medications with the same active ingredient as Mobic?

Meloxicam is sold under several brand names worldwide and is also widely available as a generic in markets where the original patent has lapsed. The broader nonsteroidal anti-inflammatory class includes many other molecules used for similar indications, although they are not freely interchangeable — profiles within the class differ. To identify a regional meloxicam product, search the active ingredient on Pill2Trip or ask a local pharmacist.

Should I consult a doctor before taking Mobic?

Yes. Mobic is a prescription medication in most jurisdictions, and long-term anti-inflammatory therapy for chronic joint conditions is individualised according to the patient's full clinical picture and concurrent medications. This is particularly relevant for travellers and people relocating, since prescription requirements and available formulations vary between countries. Any decision to start, stop, or substitute meloxicam should be made with a healthcare provider.

Mobic

Available in 26 countries